Moderna, Inc. — Investor Relations & Filings
Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Moderna, Inc. (0001682852) (Filer) | 2026-05-11 | English | |
| 4 - MODERNA, INC. (0001682852) (Filer) | 2026-03-03 | English | |
| 4 - MODERNA, INC. (0001682852) (Filer) | 2026-03-03 | English | |
| 4 - MODERNA, INC. (0001682852) (Filer) | 2026-03-03 | English | |
| 4 - MODERNA, INC. (0001682852) (Filer) | 2026-03-03 | English | |
| 4 - MODERNA, INC. (0001682852) (Filer) | 2026-02-25 | English |
Browse filings by year
10 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
OCULAR THERAPEUTIX, INC
Biopharmaceutical company developing sustained-release ther…
|
OCUL | US | Manufacturing |
|
Oculis Holding AG
Clinical-stage biopharma developing therapies for ophthalmi…
|
OCS | CH | Manufacturing |
|
Ocumension Therapeutics
Ophthalmic pharmaceutical platform dedicated to R&D and com…
|
1477 | KY | Manufacturing |
|
ODI Pharma AB
Produces and distributes regulated medicinal cannabis for t…
|
ODI | SE | Manufacturing |
|
OKYO Pharma Ltd
Clinical-stage biopharma developing drugs for eye diseases …
|
OKYO | US | Manufacturing |
|
Olema Pharmaceuticals, Inc.
A clinical-stage biopharma developing targeted therapies fo…
|
OLMA | US | Manufacturing |
|
OliX Pharmaceuticals, Inc.
Clinical-stage company developing RNAi therapeutics for der…
|
226950 | KR | Manufacturing |
|
OMEROS CORP
Develops small-molecule and protein therapeutics for unmet …
|
OMER | US | Manufacturing |
|
Omkar Pharmachem Ltd.
Manufacturer and distributor of APIs, chemical intermediate…
|
532167 | IN | Manufacturing |
|
Oncodesign Precision Medicine S.A
Develops therapeutic and diagnostic solutions for resistant…
|
ALOPM | FR | Manufacturing |
Moderna, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30610/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30610 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30610 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30610 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30610}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Moderna, Inc. (id: 30610)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.